Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-11

Clinical Trial Update: Post Market Clinical Follow-Up TOUCH® CMC 1

View source ↗

Summary

Post-market clinical follow-up trial TOUCH CMC 1 conducted by Keri Medical SA for osteoarthritis of the thumb; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Keri Medical SA | Conditions: Osteoarthritis Thumb | Status: ACTIVE_NOT_RECRUITING